natgillin/translations-raw huggingface dataset:
For the full list of side effects and restrictions of Nasym, see the package leaflet. 
Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Nasym glejte navodilo za uporabo.
How does Nasym work? 
Kako zdravilo Nasym deluje?
Nasym (bovine respiratory syncytial virus vaccine, live) 
Zdravilo Nasym (cepivo proti bovinemu respiratornemu sincicijskemu virusu, živo)
For cattle from 10 weeks of age, the vaccine is given as a single injection into the muscle followed by a second injection into the muscle 4 weeks later. 
Govedu od 10 tednov starosti se cepivo daje kot enkratna injekcija v mišico, druga injekcija v mišico pa se da štiri tedne pozneje.
Nasym contains bovine respiratory syncytial virus strain Lym-56. 
Zdravilo Nasym vsebuje bovini respiratorni sincicijski virus, sev Lym-56.
How is Nasym used? 
Kako se zdravilo Nasym uporablja?
The medicine can only be obtained with a prescription and is available as a lyophilisate (a freeze dried powder) and solvent to make either a nasal spray or an injection. 
Zdravilo je na voljo v obliki liofilizata (praška, posušenega z zamrzovanjem) in vehikla, iz katerih se pripravi pršilo za nos ali injekcija.
Nasym reduces shedding of virus and respiratory signs such as raised breathing rate, difficulty breathing, watery eyes and runny nose. 
Zdravilo Nasym zmanjša izločanje virusa in respiratorne znake, kot so pospešeno in oteženo dihanje, izcedek iz oči in nosu.
The studies confirmed the vaccine starts to be effective 3 weeks after both nasal vaccination and injection into the muscle, with effectiveness lasting 2 months after nasal vaccination and 6 months after injection into the muscle. 
Študije so potrdile, da cepivo začne učinkovati tri tedne tako po nazalnem cepljenju kot po injekciji v mišico, učinkuje pa dva meseca po nazalnem cepljenju in šest mesecev po injekciji v mišico.
Revaccination is given by injection into the muscle 2 months after the initial vaccination and then every 6 months. 
Revakcinacija se daje z injiciranjem v mišico dva meseca po začetnem cepljenju in nato vsakih šest mesecev.
The vaccine starts to be effective 3 weeks after vaccination into the muscle and protection lasts for 6 months. 
Cepivo začne učinkovati tri tedne po cepljenju v mišico, zaščita pa traja šest mesecev.
Revaccination is given as a single injection into the muscle 6 months after the initial vaccination course and then every 6 months. 
Revakcinacija se daje z injiciranjem v mišico šest mesecev po začetnem sklopu cepljenja in nato vsakih šest mesecev.
The vaccine starts to be effective 3 weeks after nasal vaccination and protection lasts for 2 months following vaccination. 
Cepivo začne učinkovati tri tedne po nazalnem cepljenju, zaščita pa traja dva meseca po cepljenju.
Nasym is a vaccine used to protect cattle against bovine respiratory syncytial virus, a disease that affects their airways. 
Zdravilo Nasym je cepivo, ki se uporablja za zaščito pred bovinim respiratornim sincicijskim virusom pri govedu.
These measures should help to protect the environment. 
Ti ukrepi pomagajo varovati okolje .
This was observed in less than 10% of the cattle treated in clinical studies. 
To so zasledili pri manj kot 10% goveda v kliničnih raziskavah.
The metabolism is qualitatively similar in rats, mini-pigs, humans, cattle and pigs, although quantitatively there are differences. 
Presnavljanje je kakovostno podobno pri podganah, mini prašičih, ljudeh, govedih in prašičih , količinsko pa se razlikuje.
Milk: 5 days 
Mleko: 5 dni
1348 Louvain-la-Neuve BELGIUM 
1348 Louvain-la-Neuve, BELGIJA
Treatment of calves with Contacera 20 minutes before dehorning reduces post-operative pain. 
Zdravljenje telet z zdravilom Contacera 20 minut pred odstranitvijo rogov zmanjša pooperativno bolečino.
6.2 Major incompatibilities 
6.2 Glavneinkompatibilnosti
For example, a horse weighing 400 kg will receive 16 ml of Contacera, a horse weighing 500 kg will receive 20 ml of Contacera, and a horse weighing 600 kg will receive 24 ml of Contacera. 
Na primer, konj, ki tehta 400 kg, bo prejel 16 ml Contaceraa, konj, ki tehta 500 kg, bo prejel 20 ml Contaceraa in konj, ki tehta 600 kg, bo prejel 24 ml za Contaceraa.
5 mg. For the full list of excipients, see section 6.1. 
5 mg Za celoten seznam pomožnih snovi glejte poglavje 6.1.
ATCvet code: QM01AC06. 
(oksikami) Oznaka ATCvet: QM01AC06
Cattle: meat and offal: 15 days; milk: 5 days Pigs: meat and offal: 5 days 
Govedo: meso in organi: 15 dni; mleko: 5 dni Prašiči: meso in organi: 5 dni
Contacera alone will not provide adequate pain relief during the dehorning procedure. 
Samo zdravilo Contacera ne zagotavlja ustreznega lajšanja bolečine med postopkom odstranjevanja rogov.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 06/12/2012 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 06/12/2012
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 15/02/2014 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 15/02/2014
This is equivalent to 1 ml of Contacera per 25 kg body weight of horse. 
To je enakovredno 1 ml Contaceraa na 25 kg telesne mase konja.
injection. 
injekcija.
Laboratory studies in cattle have not produced any evidence for teratogenic, foetotoxic, or maternotoxic effects. 
Z laboratorijskimi študijami na govedu niso bili dokazani teratogeni in fetotoksični učinki ter toksični učinki na mater.
Ethanol (96%) 159.8 mg 
Etanol 96-odstotni 159,8 mg
6.1 List of excipients - Ethanol (96%) - Poloxamer 188 - Macrogol 400 - Glycine - Sodium hydroxide - Hydrochloric acid, concentrated - Meglumine - Water for injections 
- etanol, 96-odstotni - poloksamer 188 - makrogol 400 - glicin - natrijev hidroksid - klorovodikova kislina, koncentrirana - meglumin - voda za injekcije
Cattle and pigs: 
Govedo in prašiči:
5531 AE Bladel THE NETHERLANDS 
Handelsweg 25, 5531 AE Bladel, NIZOZEMSKA
THE WORDS “KEEP OUT OF THE SIGHT AND REACH OF CHILDREN” 
BESEDILO “ZDRAVILO SHRANJUJTE IZVEN DOSEGA IN POGLEDA OTROK”
The active substance in Contacera is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) 37/2010: 
Učinkovina zdravila Contacera kot je navedena v tabeli 1(dovoljene snovi) priloge Uredbe Komisije (EU)
To be administered either mixed with a small quantity of food, prior to feeding, or directly into the mouth. 
Zdravilo dajemo zamešano v majhno količino hrane pred hranjenjem ali v gobec.
Approximately 98% of meloxicam is bound to plasma proteins. 
Porazdelitev Približno 98 % meloksikama se veže na beljakovine v plazmi.
For use in the alleviation of inflammation and the relief of pain in both acute and chronic musculoskeletal disorders, oral suspensions of meloxicam may be used for continuation of treatment at a dosage of 0.6 mg meloxicam/kg body weight, 24 hours after administration of the injection. 
Pri umirjanju vnetja in lajšanju bolečine pri akutnih in kroničnih mišično-skeletnih obolenjih lahko uporabimo peroralno suspenzijo meloksikama v odmerku po 0,6 mg meloksikama na kilogram telesne mase za nadaljevanje zdravljenja 24 ur po injekciji.
THE WORDS “FOR ANIMAL TREATMENT ONLY” For animal treatment only. 
BESEDILO ''SAMO ZA ŽIVALI'' Samo za živali.
Do not use in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. 
Ne uporabite pri konjih z obolenji prebavil, kot so zdraženost prebavil in krvavitve, pri motnjah delovanja jeter, srca ali ledvic in pri hemoragičnih obolenjih.
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. 
6.6 Posebni varnostni ukrepi za odstranjevanje neporabljenega zdravila ali odpadnih snovi Vsako neporabljeno zdravilo za uporabo v veterinarski medicini ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi zahtevami.
Do not use in case of hypersensitivity to the active substance or to any of the excipients. 
Ne uporabite v primeru preobčutljivosti na učinkovino ali na katero koli pomožno snov.
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported. 
V zelo redkih primerih se je pojavila izguba apetita, zaspanost, bolečine v trebuhu in kolitis.
Single I.M. 
Enkratna i.m.
Shelf life of the veterinary medicinal product as packaged for sale: 3 years. 
Rok uporabnosti zdravila v pakiranju za prodajo: 3 leti
Uncommon adverse reactions include transient swelling at the injection site in horses, but resolves without intervention. 
Občasni neželeni učinki pri konjih vključujejo prehodne otekline na mestu injiciranja, ki minejo brez posredovanja.
INDICATION(S) Read the package leaflet before use. 
INDIKACIJA(E) Pred uporabo preberite navodila za uporabo.
PHARMACEUTICAL FORM Oral suspension 
FARMACEVTSKA OBLIKA Peroralna suspenzija
People with known hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product. 
Osebe z znano preobčutljivostjo za nesteroidna protivnetna zdravila (NSAID) naj se izogibajo stiku z zdravilom.
In the case of overdose symptomatic treatment should be initiated. 
Pri prevelikem odmerjanju uvedemo simptomatsko zdravljenje.
After administration of the veterinary medicinal product, close the bottle by replacing the cap, wash the measuring syringe with warm water and let it dry. 
Po dajanju zdravila plastenko zaprite z zaporko in merilno brizgo pomijte s toplo vodo in posušite.
The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product. 
Uredbe Komisije (EU) št.37/2010 določa, da MRL ni potreben ali pa ne spadajo v področje uporabe
The syringe fits onto the bottle and has a 2 ml scale. 
Brizga se prilega plastenki in ima merilno lestvico z oznakami za 2ml.
4.2 Indications for use, specifying the target species Cattle: 
4.2 Indikacije za uporabo pri ciljnih živalskih vrstah Govedo:
When the product is used according to the recommended dosage regime, the oral bioavailability is approximately 98%. 
Absorpcija Če dajemo zdravilo po priporočeni shemi odmerjanja, je njegova peroralna biološka uporabnost približno
Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by intravenous E. coli endotoxin administration in calves and pigs. 
Deluje tudi antiendotoksično, saj so dokazali, da zavira nastajanje tromboksana B2, izzvano z intravenskim vnosom endotoksina E. Coli pri teletih in prašičih.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT 
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM TER PROIZVAJALCA ZDRAVILA, ODGOVORNEGA ZA SPROŠČANJE SERIJ, ČE STA
After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmax values of 2.1 µg/ml and 2.7 µg/ml were reached after 7.7 hours and 4 hours in young cattle and lactating cows, respectively. 
Po enkratnem subkutanem odmerku meloksikama po 0,5 mg/kg je znašala Cmax pri mladem govedu in kravah v obdobju laktacije 2,1 µg/ml in 2,7 µg/ml po 7,7 ure in 4 urah.
Pregnancy and lactation: Do not use in pregnant or lactating mares. 
Brejost in laktacija: Ne uporabite pri kobilah v obdobju brejosti in laktacije.
THE WORDS “KEEP OUT OF THE SIGHT AND REACH OF CHILDREN” Keep out of the sight and reach of children. 
BESEDILO “ZDRAVILO SHRANJUJTE IZVEN DOSEGA IN POGLEDA OTROK” Zdravilo shranjujte nedosegljivo otrokom.
Sodium benzoate 
Natrijevega benzoata:
BATCH NUMBER Lot {number} 
Številka serije {številka}
Single I.V. 
Enkratna i.v.
Meloxicam is eliminated with a half-life of 26 hours and 17.5 hours after subcutaneous injection in young cattle and lactating cows, respectively. 
Razpolovna doba izločanja meloksikama je po subkutani injekciji pri mladem govedu in kravah v obdobju laktacije 26 ur oziroma 17,5 ure.
Honey flavoured, off-white to yellow viscous oral suspension. 
Umazano bela do rumena viskozna peroralna suspenzija, z aromo medu.
QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: 
KAKOVOSTNA IN KOLIČINSKA SESTAVA
In very rare cases, adverse reactions typically associated with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) were observed in clinical trials (slight urticaria, diarrhoea). 
V zelo redkih primerih so v kliničnih študijah zasledili neželene učinke, ki so značilni za nesteroidna protivnetna zdravila NSAID (blaga urtikarija, driska).
See also section 4.7. 
4.3 Kontraindikacije Glejte tudi poglavje 4.7.
Cardboard box containing one HDPE bottle of 100 or 250 ml with a tamper proof child resistant closure and a polypropylene measuring syringe. 
Škatla z eno HDPE plastenko po 100 ali 250 ml, z za otroke varnim zapiralom ter polipropilensko merilno brizgo.
Not authorised for use in horses producing milk for human consumption. 
Ni dovoljena uporaba pri živalih v laktaciji, katerih mleko je namenjeno prehrani ljudi.
Manufacturers responsible for batch release: 
Proizvajalca, odgovorna za sproščanje serij:
METHOD AND ROUTE(S) OF ADMINISTRATION Cattle: 
INDIKACIJA(E) Govedo:
and 
ali
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams). 
protivnetna in protirevmatična zdravila, nesteroidna (oksikami)
ROUTES OF ADMINISTRATION Cattle: SC or IV. 
POT(I) UPORABE ZDRAVILA Govedo: s.c. ali i.v.
Saccharin sodium Carmellose sodium Silica, colloidal anhydrous Citric acid monohydrate Sorbitol, liquid (non-crystallising) Disodium phosphate dodecahydrate Sodium benzoate 
Seznam pomožnih snovi natrijev saharinat natrijev karmelozat, premreženi silicijev dioksid, koloidni, premereženi citronska kislina monohidrat sorbitol, tekoči (nekristalizirajoči)
EXPIRY DATE EXP {month/year} Once broached use by….. 
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA EXP {mesec/leto}
Shelf- life after first opening the container: 3 months. 
Rok uporabnosti po prvem odpiranju vsebnika: 3 mesece.
Cardboard box containing one colourless glass vial of 20 ml, 50 ml, 100 ml or 250 ml. 
Kartonska škatla z 1 brezbarvno stekleno injekcijsko vialo po 20 ml, 50 ml, 100 ml ali 250 ml.
Oral use. 
Peroralno dajanje.
Maximum number of piercings is 14 for the 20 ml, 50 ml and 100 ml stoppers and 20 for the 250 ml stopper. 
Največje število prebadanj zamaška je 14 -krat za viale po 20 ml, 50 ml in 100 ml in 20-krat za vialo po 250 ml .
Excipient: Sodium benzoate 
Pomožna snov: Natrijev benzoat
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate. 
Enkratna subkutana ali intravenska injekcija v odmerku po 0,5 mg meloksikama na kilogram telesne mase (to je 2,5 ml/100 kg telesne mase), po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
Do not use this veterinary medicinal product after the expiry date which is stated on the carton and vial after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na zunanji ovojnini in viali za EXP. Rok uporabnosti se nanaša na zadnji dan v mesecu.
MARKETING AUTHORISATION NUMBER(S) EU/2/12/144/005 100 ml 
ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/12/144/005 100 ml
Common adverse reactions include slight transient swelling at the injection site following subcutaneous administration in cattle and pigs. 
Pogosti neželeni učinki pri govedu in prašičih vključujejo rahlo prehodno otekanje na mestu injiciranja, po subkutanem dajanju zdravila.
In very rare cases anaphylactoid reactions, which may be serious (including fatal), when they occur, they should be treated symptomatically. 
Zelo redko se lahko pojavijo anafilaktoidne reakcije, ki so lahko resne (tudi fatalne); ko se pojavijo, jih je treba zdraviti simptomatsko.
Shelf- life after first opening the immediate packaging: 28 days Once broached, use by… 
Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni Načeto/odprto zdravilo uporabite do…
Meloxicam 20 mg 
Meloksikam 20 mg/ml
A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE 
A. PROIZVAJALEC ZDRAVILA, ODGOVOREN ZA SPROŠČANJE SERIJE B.
NAME OF THE VETERINARY MEDICINAL PRODUCT Contacera 15 mg/ml oral suspension for horses 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Contacera 15 mg/ml, peroralna suspenzija za konje
NAME OF THE VETERINARY MEDICINAL PRODUCT Contacera 15 mg/ml oral suspension for horses meloxicam 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Contacera 15 mg/ml, peroralna suspenzija za konje meloksikam
PACKAGE LEAFLET: Contacera 20 mg/ml solution for injection for cattle, pigs and horses 
Contacera 20 mg/ml raztopina za injiciranje za govedo, prašiče in konje
Active substance: 
učinkovina:
Single S.C. or I.V. 
Govedo: Enkratna s.c. ali i.v.
PACKAGE LEAFLET: Contacera 15 mg/ml oral suspension for horses 
NAVODILO ZA UPORABO Contacera 15 mg/ml, peroralna suspenzija za konje
If required, a second administration of meloxicam can be given after 24 hours. 
24 urah damo še en odmerek meloksikama.
Horses: Do not use in pregnant or lactating mares. 
Konji: Ne uporabite pri brejih kobilah ali kobilah v obdobju laktacije.
SPECIAL STORAGE CONDITIONS Do not freeze. 
POSEBNA NAVODILA ZA SHRANJEVANJE Ne zamrzujte.
THE WORDS ‘FOR ANIMAL TREATMENT ONLY' AND CONDITIONS OF RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE 
BESEDILO “SAMO ZA ŽIVALI” TER POGOJI IN OMEJITVE GLEDE OSKRBE IN
MARKETING AUTHORISATION HOLDER Zoetis Belgium SA 
Imetnik dovoljenja za promet z zdravilom Zoetis Belgium SA,
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton for 20 ml, 50 ml, 100 ml and 250 ml 
PODATKI NA ZUNANJI OVOJNINI Škatla za 20 ml, 50 ml, 100 ml ali 250 ml vialo
Marketing authorisation holder: 
Datum zadnjega podaljšanja dovoljenja za promet:
4.8 Interaction with other medicinal products and other forms of interaction Do not administer concurrently with glucocorticosteroids, other Non-Steroidal Anti-Inflammatory Drugs or with anticoagulant agents. 
4.8 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Zdravila ne smemo dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Interactions with other medicinal products and other forms of interaction: Do not administer concurrently with glucocorticosteroids, other Non-Steroidal Anti-Inflammatory Drugs or with anticoagulant agents. 
Medsebojno delovanje z drugimi zdravili in druge oblike interakcij: Ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu). 
Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) (http://www.ema.europa.eu).
Bovine, caprine 
GovedoG ovedo Koze
NAME OF THE VETERINARY MEDICINAL PRODUCT Contacera 20 mg/ml solution for injection for cattle, pigs and horses meloxicam 
Contacera 20 mg/ml raztopina za injiciranje za govedo, prašiče in konje meloksikam
Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e. 3ml/100 kg body weight). 
Enkratna intravenska injekcija odmerka po 0,6 mg meloksikama na kilogram telesne mase (to je 3,0 ml/100 kg telesne mase).
Meloxicam 20 mg Ethanol (96%) 159.8 mg Clear, yellow solution. 
Meloksikam 20 mg Etanol (96%)
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton for 100 ml or 250 ml bottle 
PODATKI NA ZUNANJI OVOJNINI Škatla za 100 ml ali 250 ml plastenko
Shelf life after first opening of the immediate packaging: 3 months. 
Rok uporabnosti po prvem odpiranju stične ovojnine: 3 mesecev
Meat and offal: 15 days; 
Meso in organi: 15 dni
Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e. 3 ml/100 kg body weight). 
Enkratna intravenska injekcija odmerka po 0,6 mg meloksikama na kilogram telesne mase (to je 3 ml na 100 kg telesne mase).
TARGET SPECIES Horses. 
CILJNE ŽIVALSKE VRSTE
ADVICE ON CORRECT ADMINISTRATION Avoid introduction of contamination during use. 
NASVET O PRAVILNI UPORABI ZDRAVILA Navedba ni smiselna.
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu). 
DATUM ZADNJE ODOBRITVE NAVODIL ZA UPORABO Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) (http://www.ema.europa.eu).
METHOD AND ROUTE(S) OF ADMINISTRATION Shake well before use. 
NAČIN IN POT(I)UPORABE
Horses: IV. 
Konji: i.v.
Meloxicam is a Non-Steroidal Anti-Inflammatory Drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects. 
Meloksikam je nesteroidno protivnetno zdravilo (NSAID) iz skupine oksikamov.
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/). 
DATUM ZADNJE ODOBRITVE NAVODIL ZA UPORABO Podrobne informacije o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) http://www.ema.europa.eu/.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Label for 100 ml and 250 ml bottles 
Nalepka za 100 ml in 250 ml plastenke
Meloxicam is a NSAID of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects. 
Deluje protivnetno, antieksudativno, analgetično in antipiretično.
Equidae 
OVOJNINAH
once a day. 
enkrat na dan.
Date of first authorisation: 04 June 2004 Date of latest renewal: 04 June 2009 
Datum prve odobritve: 04. junij 2004 Datum zadnjega podaljšanja: 04. junij 2009
Over 75 % of patients were less than 13 years of age. 
Več kot 75 % bolnikov je bilo mlajših od 13 let.
You will probably need to lie down until you feel better. 
Do izboljšanja boste verjetno morali ležati.
3 years After first opening: 6 months. 
3 leta Po prvem odprtju: 6 mesecev.
• altered or increased sexual interest, 
• spremenjeno ali povečano spolno zanimanje,
Up to three injections in 24 hours may be given. 
V 24 urah lahko prejmete do tri injekcije.
• thoughts of suicide, suicide attempt and suicide, 
• misli na samomor, poskus samomora in samomor,
The European Medicines Agency has deferred the obligation to submit the results of studies with 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z zdravilom
The doctor may also want to measure your blood pressure and pulse. 
Zdravnik vam bo morda tudi izmeril krvni tlak in pulz.
The medical supervision and monitoring should continue until the patient recovers. 
Zdravniški nadzor in spremljanje je treba nadeljevati dokler si bolnik ne opomore.
• if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na aripiprazol ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
It does not matter whether you take it with or without food. 
Ni pomembno, ali ga vzamete s hrano ali brez nje.
No long-term data are available with regard to the efficacy and the safety of aripiprazole in this fluctuating disorder. 
Dolgoročni podatki za učinkovitost in varnost aripiprazola pri tej spremenljivi motnji niso na voljo.
18 months After opening: use product immediately. 
18 mesecev Po odprtju: zdravilo uporabite nemudoma po odprtju.
It is ready to use and intended for short-term use only (see section 5.1). 
Namenjena je le za kratkotrajno uporabo (glejte poglavje 5.1).